Engaging a Rising China through Tropical Disease Elimination
Submitted by Sabin on
© 2012 • Sabin Vaccine Institute • 2000 Pennsylvania Ave, NW, Suite 7100 • Washington, DC 20006 • t. (202) 842-5025
Clinical Trials for First-Ever Human Hookworm Vaccine Advance
Submitted by Sabin on
Phase 1 Clinical Trial in Brazil begins Testing at Brazilian Field Site
Industry, NGOs Share Joint Progress on Neglected Tropical Disease Control
Submitted by Sabin on
Successful Public-Private Partnerships Hope to Encourage Increased Private and Public Sector Participation.
Eisai and the Sabin Vaccine Institute Partner to Develop Vaccines for Chagas Disease and Leishmaniasis
Submitted by Sabin on
The Sabin Vaccine Institute Product Development Partnership (Sabin PDP) today announced a new co